David Windley
Stock Analyst at Jefferies
(4.49)
# 310
Out of 4,711 analysts
187
Total ratings
66.06%
Success rate
13.31%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Downgrades: Underperform | $68 → $52 | $59.58 | -12.72% | 26 | Dec 10, 2024 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $14.09 | -14.83% | 1 | Dec 10, 2024 | |
| HUM Humana | Downgrades: Hold | $419 → $253 | $247.10 | +2.39% | 18 | Oct 7, 2024 | |
| FTRE Fortrea Holdings | Downgrades: Hold | $25 → $21 | $19.26 | +9.03% | 2 | Sep 25, 2024 | |
| MEDP Medpace Holdings | Downgrades: Hold | $415 → $345 | $337.28 | +2.29% | 5 | Sep 25, 2024 | |
| CI The Cigna Group | Maintains: Buy | $402 → $422 | $276.92 | +52.39% | 17 | Sep 17, 2024 | |
| MOH Molina Healthcare | Maintains: Hold | $354 → $297 | $294.73 | +0.77% | 23 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Hold | $266 → $242 | $197.27 | +22.67% | 4 | Jul 24, 2024 | |
| UNH UnitedHealth Group | Upgrades: Buy | $481 → $647 | $500.13 | +29.37% | 26 | Jul 17, 2024 | |
| NOTV Inotiv | Downgrades: Hold | $12 → $3.75 | $4.08 | -8.09% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $365.96 | +65.05% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $524.43 | -28.49% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $13.24 | +17.07% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $224.15 | +20.46% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $10.71 | +44.72% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $331.40 | +61.74% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $20.56 | +41.05% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $233 → $203 | $185.77 | +9.27% | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $276 → $302 | $207.51 | +45.54% | 14 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $9.44 | +2,527.12% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.49 | - | 5 | Oct 9, 2017 |
Centene
Dec 10, 2024
Downgrades: Underperform
Price Target: $68 → $52
Current: $59.58
Upside: -12.72%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $14.09
Upside: -14.83%
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $247.10
Upside: +2.39%
Fortrea Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $25 → $21
Current: $19.26
Upside: +9.03%
Medpace Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $415 → $345
Current: $337.28
Upside: +2.29%
The Cigna Group
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $276.92
Upside: +52.39%
Molina Healthcare
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $294.73
Upside: +0.77%
IQVIA Holdings
Jul 24, 2024
Downgrades: Hold
Price Target: $266 → $242
Current: $197.27
Upside: +22.67%
UnitedHealth Group
Jul 17, 2024
Upgrades: Buy
Price Target: $481 → $647
Current: $500.13
Upside: +29.37%
Inotiv
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $4.08
Upside: -8.09%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $365.96
Upside: +65.05%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $524.43
Upside: -28.49%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $13.24
Upside: +17.07%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $224.15
Upside: +20.46%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $10.71
Upside: +44.72%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $331.40
Upside: +61.74%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $20.56
Upside: +41.05%
Mar 28, 2023
Maintains: Hold
Price Target: $233 → $203
Current: $185.77
Upside: +9.27%
Sep 14, 2021
Maintains: Buy
Price Target: $276 → $302
Current: $207.51
Upside: +45.54%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $9.44
Upside: +2,527.12%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.49
Upside: -